title: [Immunisation schedule of the Spanish Association of Paediatrics: 2013 recommendations].
abstract: The Advisory Committee on Vaccines of the Spanish Association of Paediatrics (CAV-AEP) updates the immunisation schedule every year, taking into account epidemiological data as well as evidence on the safety, effectiveness and efficiency of vaccines. The present schedule includes levels of recommendation. We have graded as routine vaccinations those that the CAV-AEP consider all children should receive; as recommended those that fit the profile for universal childhood immunisation and would ideally be given to all children, but that can be prioritised according to the resources available for their public funding; and as risk group vaccinations those that specifically target individuals in situations of risk. Immunisation schedules tend to be dynamic and adaptable to ongoing epidemiological changes. Nevertheless, the achievement of a unified immunisation schedule in all regions of Spain is a top priority for the CAV-AEP. Based on the latest epidemiological trends, CAV-AEP follows the innovations proposed in the last year's schedule, such as the administration of the first dose of the MMR and the varicella vaccines at age 12 months and the second dose at age 2-3 years, as well as the administration of the Tdap vaccine at age 4-6 years, always followed by another dose at 11-14 years of age, preferably at 11-12 years. The CAV-AEP believes that the coverage of vaccination against human papillomavirus in girls aged 11-14 years, preferably at 11-12 years, must increase. It reasserts its recommendation to include vaccination against pneumococcal disease in the routine immunisation schedule. Universal vaccination against varicella in the second year of life is an effective strategy and therefore a desirable objective. Vaccination against rotavirus is recommended in all infants due to the morbidity and elevated healthcare burden of the virus. The Committee stresses the need to vaccinate population groups considered at risk against influenza and hepatitis A. Finally, it emphasizes the need to bring incomplete vaccinations up to date following the catch-up immunisation schedule.
authors.affiliation: dmp.malaga@gmail.com
authors.forename: D
authors.initials: D
authors.lastname: Moreno-Pérez
authors.forename: F J
authors.initials: FJ
authors.lastname: Álvarez García
authors.forename: J
authors.initials: J
authors.lastname: Arístegui Fernández
authors.forename: F
authors.initials: F
authors.lastname: Barrio Corrales
authors.forename: M J
authors.initials: MJ
authors.lastname: Cilleruelo Ortega
authors.forename: J M
authors.initials: JM
authors.lastname: Corretger Rauet
authors.forename: J
authors.initials: J
authors.lastname: González-Hachero
authors.forename: T
authors.initials: T
authors.lastname: Hernández-Sampelayo Matos
authors.forename: M
authors.initials: M
authors.lastname: Merino Moína
authors.forename: L
authors.initials: L
authors.lastname: Ortigosa Del Castillo
authors.forename: J
authors.initials: J
authors.lastname: Ruiz-Contreras
mesh_terms: D000293:Adolescent; D019433:Chickenpox Vaccine; D002648:Child; D002675:Child, Preschool; D022362:Hepatitis A Vaccines; D006801:Humans; D007115:Immunization Schedule; D007223:Infant; D007252:Influenza Vaccines; D022542:Measles-Mumps-Rubella Vaccine; D022401:Meningococcal Vaccines; D038542:Neisseria meningitidis, Serogroup C / Q000276:immunology; D053918:Papillomavirus Vaccines; D022242:Pneumococcal Vaccines; D022243:Rotavirus Vaccines; D014611:Vaccination
chemical_list: D019433:Chickenpox Vaccine; D022362:Hepatitis A Vaccines; D007252:Influenza Vaccines; D022542:Measles-Mumps-Rubella Vaccine; D022401:Meningococcal Vaccines; D053918:Papillomavirus Vaccines; D022242:Pneumococcal Vaccines; D022243:Rotavirus Vaccines